S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
NASDAQ:ELEV

Elevation Oncology Short Interest Ratio and Short Volume

$7.83
+0.02 (+0.26 %)
(As of 10/25/2021 10:23 AM ET)
Add
Compare
Today's Range
$7.83
$7.83
50-Day Range
$7.51
$12.98
52-Week Range
$7.38
$16.22
Volume62 shs
Average Volume62,746 shs
Market Capitalization$181.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Elevation Oncology (NASDAQ:ELEV) Short Interest Data

Current Short Volume138,700 shares
Previous Short Volume3,200 shares
Change Vs. Previous Month+4,234.38%
Dollar Volume Sold Short$1.08 million
Short Interest Ratio / Days to Cover2.7
Last Record DateSeptember, 30 2021
Outstanding Shares23,226,000 shares
Float Size13,970,000 shares
Short Percent of Float0.99%
Today's Trading Volume62 shares
Average Trading Volume62,746 shares
Today's Volume Vs. Average-99.90%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Elevation Oncology ?

Sign up to receive the latest short interest report for Elevation Oncology and its competitors with MarketBeat's FREE newsletter.

Elevation Oncology (NASDAQ:ELEV) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2021138,700 shares $1.08 million +4,234.4%1.0%2.7 $7.79
9/15/20213,200 shares $31,680.00 -79.6%0.0%0 $9.90
8/31/202115,700 shares $183,690.00 -17.8%0.1%0.1 $11.70
8/13/202119,100 shares $219,650.00 No Change0.2%0.2 $11.50

Elevation Oncology (NASDAQ:ELEV) Short Interest FAQ













Elevation Oncology (NASDAQ:ELEV) Short Interest Frequently Asked Questions

What is Elevation Oncology's current short interest?

Short interest is the volume of Elevation Oncology shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 138,700 shares of ELEV short. 0.99% of Elevation Oncology's shares are currently sold short. Learn More on Elevation Oncology's current short interest.

What is a good short interest ratio for Elevation Oncology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Elevation Oncology currently has a short interest ratio of 3.0. Learn More on a good short interest ratio for Elevation Oncology

What is a good short interest percentage for Elevation Oncology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.99% of Elevation Oncology's floating shares are currently sold short.

Is Elevation Oncology's short interest increasing or decreasing?

Elevation Oncology saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 138,700 shares, an increase of 4,234.4% from the previous total of 3,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Elevation Oncology's float size?

Elevation Oncology currently has issued a total of 23,226,000 shares. Some of Elevation Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elevation Oncology currently has a public float of 13,970,000 shares.

How does Elevation Oncology's short interest compare to its competitors?

0.99% of Elevation Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Elevation Oncology: Graphite Bio, Inc. (12.89%), Aligos Therapeutics, Inc. (7.41%), Curis, Inc. (12.00%), Talaris Therapeutics, Inc. (5.07%), Molecular Partners AG (0.00%), Taysha Gene Therapies, Inc. (13.02%), Tarsus Pharmaceuticals, Inc. (3.49%), Finch Therapeutics Group, Inc. (1.43%), Acumen Pharmaceuticals, Inc. (2.42%), and Precision BioSciences, Inc. (4.89%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Elevation Oncology stock?

Short selling ELEV is an investing strategy that aims to generate trading profit from Elevation Oncology as its price is falling. Elevation Oncology's stock is trading up $0.02 today. To short Elevation Oncology stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Elevation Oncology will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Elevation Oncology?

A short squeeze for Elevation Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELEV, which in turn drives the price of the stock up even further.

How often is Elevation Oncology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELEV, twice per month. The most recent reporting period available is September, 30 2021.



This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.